PMC:7152526 / 15871-16364
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 368 | 255-262 | Species | denotes | patient | Tax:9606 |
| 369 | 383-391 | Chemical | denotes | steroids | MESH:D013256 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T109 | 56-62 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T110 | 307-313 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T111 | 448-454 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T112 | 459-467 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T26 | 125-130 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T161 | 56-62 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T162 | 307-313 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T163 | 448-454 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T73 | 362-378 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T74 | 383-391 | Chemical | denotes | steroids | http://purl.obolibrary.org/obo/CHEBI_35341 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T114 | 0-63 | Sentence | denotes | There are still limitations for the use of convalescent plasma. |
| T115 | 64-200 | Sentence | denotes | Scientific evidence is insufficient due to the lack of large-scale clinical trials that may be representative of the target populations. |
| T116 | 201-284 | Sentence | denotes | Second, the number of antibodies administered to each patient was not standardized. |
| T117 | 285-493 | Sentence | denotes | Finally, convalescent plasma usually proceeds with other treatments, such as antiviral agents and steroids, which can affect the relationship between convalescent plasma and antibody, confounding the results. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T257 | 56-62 | UBERON:0001969 | denotes | plasma |
| T258 | 223-233 | GO:0042571 | denotes | antibodies |
| T259 | 307-313 | UBERON:0001969 | denotes | plasma |
| T260 | 362-378 | CHEBI:22587;CHEBI:22587 | denotes | antiviral agents |
| T261 | 383-391 | CHEBI:35341;CHEBI:35341 | denotes | steroids |
| T262 | 448-454 | UBERON:0001969 | denotes | plasma |
| T263 | 459-467 | GO:0042571 | denotes | antibody |
| T70069 | 56-62 | UBERON:0001969 | denotes | plasma |
| T12503 | 223-233 | GO:0042571 | denotes | antibodies |
| T97864 | 307-313 | UBERON:0001969 | denotes | plasma |
| T81580 | 362-378 | CHEBI:22587;CHEBI:22587 | denotes | antiviral agents |
| T90909 | 383-391 | CHEBI:35341;CHEBI:35341 | denotes | steroids |
| T12148 | 448-454 | UBERON:0001969 | denotes | plasma |
| T76341 | 459-467 | GO:0042571 | denotes | antibody |